DL-DithiothreitolCAS# 3483-12-3 |
- Calyculin A
Catalog No.:BCC2457
CAS No.:101932-71-2
- Fumonisin B1
Catalog No.:BCC2461
CAS No.:116355-83-0
- Calcineurin Autoinhibitory Peptide
Catalog No.:BCC2456
CAS No.:148067-21-4
- Ceramide
Catalog No.:BCC2458
CAS No.:3102-57-6
- Fostriecin sodium salt
Catalog No.:BCC2460
CAS No.:87860-39-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 3483-12-3 | SDF | Download SDF |
PubChem ID | 439196 | Appearance | Powder |
Formula | C4H10O2S2 | M.Wt | 154.25 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | DL-Dithiothreitol; Cleland’s reagent | ||
Solubility | Soluble to 100 mM in sterile water | ||
Chemical Name | (2R,3R)-1,4-bis(sulfanyl)butane-2,3-diol | ||
SMILES | C(C(C(CS)O)O)S | ||
Standard InChIKey | VHJLVAABSRFDPM-IMJSIDKUSA-N | ||
Standard InChI | InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Reagent for maintaining SH groups in the reduced state. |
DL-Dithiothreitol Dilution Calculator
DL-Dithiothreitol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.483 mL | 32.4149 mL | 64.8298 mL | 129.6596 mL | 162.0746 mL |
5 mM | 1.2966 mL | 6.483 mL | 12.966 mL | 25.9319 mL | 32.4149 mL |
10 mM | 0.6483 mL | 3.2415 mL | 6.483 mL | 12.966 mL | 16.2075 mL |
50 mM | 0.1297 mL | 0.6483 mL | 1.2966 mL | 2.5932 mL | 3.2415 mL |
100 mM | 0.0648 mL | 0.3241 mL | 0.6483 mL | 1.2966 mL | 1.6207 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Dithiothreitol (DTT) is the common name for a small-molecule redox reagent known as Cleland's reagent as a reducing or deprotecting agent for thiolated DNA.
References:
[1]. Dithiothreitol, From Wikipedia
- 4'-Demethyleucomin
Catalog No.:BCN5283
CAS No.:34818-83-2
- Marilactone
Catalog No.:BCN7363
CAS No.:34818-17-2
- 8-Acetonyldihydroavicine
Catalog No.:BCN3303
CAS No.:348098-59-9
- BAY 57-1293
Catalog No.:BCC4050
CAS No.:348086-71-5
- Boc-Met(O)-OH
Catalog No.:BCC3425
CAS No.:34805-21-5
- H-Tyr(Bzl)-OMe.HCl
Catalog No.:BCC3132
CAS No.:34805-17-9
- H-D-Met-OH
Catalog No.:BCC2997
CAS No.:348-67-4
- Z-Asp(OBzl)-OH
Catalog No.:BCC2791
CAS No.:3479-47-8
- Sodium usnate
Catalog No.:BCN8376
CAS No.:34769-44-3
- ITX3
Catalog No.:BCC6066
CAS No.:347323-96-0
- Ferrostatin-1 (Fer-1)
Catalog No.:BCC2323
CAS No.:347174-05-4
- Incensole acetate
Catalog No.:BCN3830
CAS No.:34701-53-6
- Bz-Tyr-Oet
Catalog No.:BCC3122
CAS No.:3483-82-7
- Metiamide
Catalog No.:BCC1742
CAS No.:34839-70-8
- 12-Hydroxyabietic acid
Catalog No.:BCN5284
CAS No.:3484-61-5
- Methyl 3-methoxyacrylate
Catalog No.:BCN2258
CAS No.:34846-90-7
- Optovin
Catalog No.:BCC6323
CAS No.:348575-88-2
- Coptisine
Catalog No.:BCN6320
CAS No.:3486-66-6
- Palmatine
Catalog No.:BCN5285
CAS No.:3486-67-7
- UK 383367
Catalog No.:BCC2308
CAS No.:348622-88-8
- Vineridine
Catalog No.:BCN5286
CAS No.:3489-06-3
- HC-030031
Catalog No.:BCC4910
CAS No.:349085-38-7
- GSK 137647
Catalog No.:BCC8045
CAS No.:349085-82-1
- JX 401
Catalog No.:BCC7443
CAS No.:349087-34-9
Suppression of GABA(B) receptor function in vivo by disulfide reducing agent, DL-dithiothreitol (DTT).[Pubmed:14760512]
Psychopharmacology (Berl). 2004 Jul;174(2):283-90.
RATIONALE: A recent in-vitro study demonstrated that the potent disulfide reducing agent, DL-Dithiothreitol (DTT), may alter the structural stability of the GABA(B) receptor, probably inactivating the disulfide bonds between four cysteine residues located in the GABA(B1(a)) receptor structure. OBJECTIVES: The present study was designed to evaluate whether DTT treatment was capable of antagonizing some behavioral effects of pharmacological stimulation of the GABA(B) receptor. METHODS: Experiments on sedation/hypnosis induced by the GABA(B) receptor agonists baclofen, SKF 97541, CGP 44532 and gamma-hydroxybutyric acid (GHB) in DBA mice and selectively bred GHB-sensitive (GHB-S) rats, and a GHB drug discrimination study in Long Evans rats were conducted. Specificity of the DTT action on the GABA(B) receptor was investigated by assessing its effect on the sedative/hypnotic effect induced by diazepam, ketamine and ethanol. RESULTS: DTT prevented the sedative/hypnotic effect of all GABA(B) receptor agonists tested and also reversed baclofen-induced sedation/hypnosis. In contrast, DTT had no effect on, or even potentiated, sedation/hypnosis produced by diazepam, ketamine or ethanol. DTT completely blocked the discriminative stimulus effects of GHB. CONCLUSIONS: These results are discussed in terms of DTT altering the stability of the binding domain of the GABA(B) receptor, hindering the drug-receptor interaction.
Accumulation and stripping behavior of silver ions at dl-dithiothreitol self-assembled monolayer modified gold electrodes.[Pubmed:18968934]
Talanta. 2003 Mar 1;59(3):501-7.
Silver ions can be entrapped at the DL-Dithiothreitol (HSCH(2)(CHOH)(2)CH(2)SH, DTT) self-assembled monolayer films modified gold electrodes. When the potential was made moving, an anodic peak was observed at about 0.23 V (vs. SCE). When the electrode Au/DTT was modified with dodecyl mercaptan further, more Ag (I) can be accumulated and the peak grows. Conditions, such as solution pH and supporting electrolyte, were optimized for Ag (I) determination. Under the selected conditions, i.e. 0.010 M pH 4.3 potassium hydrogen phthalate, preconcentration time of 5 min at open circuit, the anodic peak height is linear to the concentration of Ag (I) in the small range of 0.6-2.4 muM. The influence of some ions on the determination of Ag (I) was examined. The Br(-) ion makes the peak decrease and NCS(-) makes the peak increase. But the determination is not interfered by 1000-fold Pb(2+), Cd(2+), Hg(2+), Fe(3+), Ni(2+), Co(2+), Cu(2+) and Sn(2+) when EDTA was added into the solution. The mechanism involved was discussed.